The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience
Authors
Keywords
Glioblastoma, Malignant glioma, BCNU wafer, Temozolomide, Multimodal therapy
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 113, Issue 2, Pages 163-174
Publisher
Springer Nature
Online
2013-03-27
DOI
10.1007/s11060-013-1110-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy w
- (2012) Emmanuèle Lechapt-Zalcman et al. CANCER
- Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: Efficacy and toxicity
- (2012) Petra Miglierini et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy
- (2012) Christopher M. McPherson et al. JOURNAL OF NEURO-ONCOLOGY
- Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma
- (2012) S. Ulmer et al. NEURO-ONCOLOGY
- Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion
- (2011) Walter Stummer et al. ACTA NEUROCHIRURGICA
- Retrospective Comparison of Chemoradiotherapy Followed by Adjuvant Chemotherapy, With or Without Prior Gliadel Implantation (Carmustine) After Initial Surgery in Patients With Newly Diagnosed High-Grade Gliomas
- (2011) Georges Noël et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Space-occupying cyst development in the resection cavity of malignant gliomas following Gliadel® implantation – incidence, therapeutic strategies, and outcome
- (2011) Lutz Dörner et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
- (2011) Dagmar Beier et al. Molecular Cancer
- High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) R. Stupp et al. ANNALS OF ONCOLOGY
- Biodegradable Carmustine Wafers (Gliadel) Alone or in Combination with Chemoradiotherapy: The French Experience
- (2010) Philippe Menei et al. ANNALS OF SURGICAL ONCOLOGY
- The paradoxical effect of bevacizumab in the therapy of malignant gliomas
- (2010) E. M. Thompson et al. NEUROLOGY
- First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience
- (2010) Hans Christoph Bock et al. NEUROSURGICAL REVIEW
- Risk Management in the Treatment of Malignant Gliomas with BCNU Wafer Implants
- (2010) A. Giese et al. Central European neurosurgery
- Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation
- (2009) Philippe Metellus et al. CANCER
- Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy
- (2009) Mary Lou Affronti et al. CANCER
- Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme
- (2009) J. A. Quinn et al. CLINICAL CANCER RESEARCH
- The safety of temozolomide in the treatment of malignancies
- (2009) Van Anh Trinh et al. Expert Opinion On Drug Safety
- Long-Term Survival of Patients With Glioblastoma Treated With Radiotherapy and Lomustine Plus Temozolomide
- (2009) Martin Glas et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
- (2009) Jennifer A. Quinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma
- (2008) J. N. Sarkaria et al. CLINICAL CANCER RESEARCH
- Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience
- (2008) Michael Sabel et al. CURRENT MEDICAL RESEARCH AND OPINION
- A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients
- (2008) Edward Pan et al. JOURNAL OF NEURO-ONCOLOGY
- Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme
- (2008) Matthew J. McGirt et al. JOURNAL OF NEUROSURGERY
- Abstracts for the Eighth Congress of the European Association for Neuro-Oncology (EANO)
- (2008) NEURO-ONCOLOGY
- New (alternative) temozolomide regimens for the treatment of glioma
- (2008) Wolfgang Wick et al. NEURO-ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now